Liquidia Corp (LQDA) stock
LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)
Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –
Liquidia price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Liquidia's price to sales ratio was 10.9× on Nov 11, 2026, against 40.9× a year earlier. Over the last 5 years it ranged from 6.0× to 123.0×, with a median of 30.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.9× | −32.4 |
| 2025 | Dec 31, 2025 | 43.3× | −20.4 |
| 2024 | Dec 31, 2024 | 63.7× | +21.1 |
| 2023 | Dec 29, 2023 | 42.6× | +12.8 |
| 2022 | Dec 30, 2022 | 29.8× | +5.4 |
| 2021 | Dec 31, 2021 | 24.4× | +14.1 |
| 2020 | Dec 31, 2020 | 10.3× | – |
See a number that looks wrong?